AMELIA KISER: Open Payments
NPI 1982131801 · PRESTONSBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$759 in 35 payments from 9 companies in 2025. Trend: 2023 $339 · 2024 $511 · 2025 $759
Food & beverage: $759
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 12 | $229 |
| Janssen Pharmaceuticals, Inc | 5 | $190 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $104 |
| E.R. Squibb & Sons, L.L.C. | 3 | $60 |
| ABBVIE INC. | 2 | $49 |
| Corium, LLC | 4 | $49 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
Products named: ARISTADA, INVEGA SUSTENNA, CAPLYTA, COBENFY, VRAYLAR, Azstarys, Auvelity, LYBALVI.
Industry payments across KY — which companies pay providers there.
